Age-adjusted D-dimer to rule out deep vein thrombosis:Findings from the PALLADIO algorithm by 
  
 University of Groningen
Age-adjusted D-dimer to rule out deep vein thrombosis
PALLADIO Study Investigators; Riva, N.; Camporese, G.; Iotti, M.; Bucherini, E.; Righini, M.;
Kamphuisen, P. W.; Verhamme, P.; Douketis, J. D.; Tonello, C.
Published in:
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
DOI:
10.1111/jth.13905
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2018
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
PALLADIO Study Investigators (2018). Age-adjusted D-dimer to rule out deep vein thrombosis: Findings
from the PALLADIO algorithm. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 16(2), 271-278.
https://doi.org/10.1111/jth.13905
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
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Essentials
• The accuracy of the age-adjusted D-dimer in suspected
venous thromboembolism is still debated.
• We assessed the performance of age-adjusted D-dimer
combined with the PALLADIO algorithm.
• The age-adjusted threshold can reduce the need for
imaging tests compared to the fixed cut-off.
• The safety of this approach should be confirmed in
large management studies.
Summary. Background: Age-adjusted D-dimer has been
proposed to increase specificity for the diagnosis of
venous thromboembolism (VTE). However, the accuracy
of this threshold has been recently questioned. Objec-
tives: To assess the diagnostic performance of
age-adjusted D-dimer combined with clinical pretest prob-
ability (PTP) in patients with suspected deep vein throm-
bosis (DVT). Methods: PALLADIO (NCT01412242) was
a multicenter management study that validated a new
diagnostic algorithm, incorporating PTP, D-dimer (using
the manufacturer’s cut-off) and limited or extended com-
pression ultrasonography (CUS) in outpatients with clini-
cally suspected DVT. Patients with unlikely PTP and
negative D-dimer had DVT ruled out without further
testing (group 1); patients with likely PTP or positive D-
dimer underwent limited CUS (group 2); patients with
likely PTP and positive D-dimer underwent extended
CUS (group 3). Patients with DVT ruled out at baseline
had a 3-month follow-up. In this post-hoc analysis we
evaluated age-adjusted D-dimer cut-off (defined as age
times 10 lg L1, or age times 5 lg L1 for D-dimers with
a lower manufacturer’s cut-off, in patients
> 50 years). Results: In total, 1162 patients were enrolled.
At initial visit, DVT was detected in 4.0% of patients in
group 2 and 53.0% in group 3. The age-adjusted D-
dimer, compared with the fixed cut-off, resulted in 5.1%
(95% CI, 4.0–6.5%) reduction of CUS. The incidence of
symptomatic VTE during follow-up was: 0.24% (95% CI,
0.04–1.37) in group 1; 1.12% (95% CI, 0.44–2.85) in
group 2; and 1.89% (95% CI, 0.64–5.40) in group
3. Conclusions: The PALLADIO algorithm using age-
adjusted D-dimer slightly decreased the number of
required imaging tests, but this approach should be con-
firmed in large management studies.
Keywords: algorithms; diagnosis; outpatients; ultrasonography;
venous thrombosis.
Introduction
D-dimer is a fibrin degradation product, and therefore a
marker of coagulation activation and fibrinolysis [1]. The
main clinical application of D-dimer is in the diagnostic
algorithm for venous thromboembolism (VTE), both for
deep vein thrombosis (DVT) and pulmonary embolism
(PE). D-dimer has a high sensitivity and negative predic-
tive value [2], but a low specificity, being raised by a num-
ber of different conditions, such as cancer, infections,
trauma and heart failure, among others [3]. When
included in the diagnostic algorithm for VTE, D-dimer
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must be integrated with clinical pretest probability (PTP)
scores (such as the Wells score or the revised Geneva
score [4–6]) and VTE diagnosis should be confirmed by
specific diagnostic imaging tests (such as compression
ultrasound [CUS] for DVT or computed tomography pul-
monary angiography [CTPA] for PE). The advantage of
using D-dimer is to avoid unnecessary imaging tests in
patients with a low PTP and negative D-dimer results
[7,8]. However, D-dimer concentrations normally increase
with age, and similarly the percentage of false-positive
results: it has been reported that the specificity of D-
dimer drops from 67% in patients ≤ 40 years to 10% in
patients ≥ 80 years [9]. In order to increase the specificity
without reducing the high sensitivity of D-dimer, an
age-adjusted cut-off has been recently proposed [10–12].
Compared with the standard fixed cut-off, the age-
adjusted D-dimer showed increased specificity in patients
with suspected DVT or PE [10,12]. However, the use of
this threshold has been recently questioned by studies
showing that the negative predictive value was not better
than the conventional threshold [13,14]. Furthermore,
although the safety of the age-adjusted D-dimer cut-off in
patients with suspected PE has already been validated in
a management study [12], data in patients with suspected
DVT are scarce and derived only from retrospective analy-
sis [10,13]. Therefore, more evidence is needed on the accu-
racy of the age-adjusted threshold in the diagnosis of DVT.
The Prospective Algorithm incorporating Limited and
whole-Leg Assessment of the Deep venous system In
symptomatic Outpatients (PALLADIO) study [15]
assessed the performance of a diagnostic algorithm
(combining D-dimer, PTP and limited or extended
CUS) that aimed to simplify the approach to patients
with suspected DVT. The combination of PTP and D-
dimer indeed allowed the identification of three groups
of patients: (i) patients in whom DVT could be safely
ruled out without the need for CUS; (ii) patients who
needed a single limited CUS, without the need for a
repeated CUS after a week; and (iii) patients who
needed an extended CUS, in order to assess both proxi-
mal and distal veins. Therefore, the PALLADIO algo-
rithm can eliminate the need for repeated serial CUS
and reduce the risk of detecting isolated distal DVTs of
uncertain clinical significance. The aim of this post-hoc
analysis was to assess the accuracy of an age-adjusted
D-dimer cut-off using the database of the PALLADIO
study [15].
Materials and methods
Study design and population
The PALLADIO study (ClinicalTrials.gov number:
NCT01412242) was an international multicenter manage-
ment study of patients with suspected DVT [15]. Briefly,
inclusion criteria were consecutive adult outpatients with
clinically suspected DVT of the lower extremities,
referred to eight thrombosis centers in five different
countries from March 2011 to July 2014 (see Appendix
for the full list of contributors). Exclusion criteria were:
previous DVT in the same leg; concomitant suspicion of
PE; ongoing or planned anticoagulant treatment for
other indications; need for pharmacological thrombopro-
phylaxis because of recent surgery, trauma or acute
medical disease; inpatients; pregnancy; unavailability for
follow-up; and age < 18 years. The study was approved
by the local research and ethics committees and written
informed consent was obtained from all patients before
inclusion.
Study procedures
All patients underwent assessment of the pretest probabil-
ity (PTP) of DVT using the Wells score [4] and measure-
ment of the D-dimer. Different D-dimer tests were
performed in each participating center and, in the original
study, they were interpreted according to the manufac-
turer’s cut-off (as reported in Table S1). Patients were
divided into three groups based on PTP and D-dimer,
according to the diagnostic algorithm summarized in
Fig. 1. Patients with unlikely PTP and negative D-dimer
had DVT ruled out without further testing (group 1).
Patients with either likely PTP or positive D-dimer had a
lower limb compression ultrasound (CUS) limited to the
proximal veins (group 2). Patients with both likely PTP
and positive D-dimer had a whole-leg CUS (group 3).
Details regarding the ultrasonography technique have been
reported in the original publication of the PALLADIO
study [15].
All patients with DVT ruled out at baseline underwent
a 3-month clinical or telephone follow-up. Patients with a
suspicion of DVT or PE during follow-up underwent
additional diagnostic tests at the discretion of the attend-
ing physicians (CUS, CTPA or ventilation-perfusion
scan). Causes of death were adjudicated based on autopsy
reports, if available, or clinical reports. All reported clini-
cal outcomes were reviewed and adjudicated by a central
adjudication committee composed of three authors (P.P.,
J.D.D. and M.R.), unaware of each patient management
group.
Outcomes
The main outcome of the original PALLADIO study was
the incidence of objectively documented DVT or PE dur-
ing follow-up in patients in whom DVT was ruled out at
baseline, using the manufacturer’s cut-off for D-dimer.
The primary aim of this post-hoc analysis was to assess
the incidence of objectively documented thromboembolic
events during follow-up by applying the new cut-offs. The
secondary aim was the reduction of required imaging
tests.
© 2017 International Society on Thrombosis and Haemostasis
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Statistical analysis
Baseline patient characteristics were expressed by means
of descriptive statistics. Continuous variables were
reported as mean with standard deviation (SD) or as
median with interquartile range (IQR), according to the
Wilk-Shapiro test; categorical variables were reported as
counts and percentages. The incidence of venous throm-
boembolism was expressed as a percentage (with 95%
Wilson confidence interval [CI]).
For the purpose of this post-hoc analysis, instead of
using the manufacturer’s cut-off for D-dimers, we applied
an age-adjusted cut-off, calculated by multiplying the
patient’s age by 10 lg L1 for patients older than
50 years, and keeping the standard fixed manufacturer’s
threshold of 500 lg L1 for patients up to 50 years, as
applied in several recent studies [10–12]. However,
because three participating centers in the PALLADIO
study used D-dimers with a lower manufacturer’s cut-off
(either 225 lg L1 or 230 lg L1), we considered a
halved age-adjusted threshold for these centers, defined as
the patient’s age times 5 lg L1 for patients older than
50 years, and the conventional fixed manufacturer’s
threshold (either 225 lg L1 or 230 lg L1) for patients
up to 50 years, as suggested by a previous laboratory
study [16]. The manufacturer’s and age-adjusted D-dimer
cut-offs are summarized in Table S1. In a sensitivity anal-
ysis, we evaluated whether the traditional age-adjusted
cut-off (age times 10 lg L1) and the halved age-adjusted
cut-off (age times 5 lg L1) resulted in a different inci-
dence of VTE at 3-month follow-up.
We also calculated sensitivity, specificity, positive pre-
dictive value (PPV) and negative predictive value (NPV)
with 95% confidence interval (CI) for the age-adjusted D-
dimer in the entire cohort and within each PTP strata.



















Fig. 1. Algorithm of the PALLADIO study. DVT, deep vein thrombosis; PTP, pretest probability; CUS, compression ultrasound; DD, D-dimer.
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above the threshold and VTE at the initial visit or during
follow-up. True negative was defined as patients with D-
dimer level below the threshold and without VTE.
Data analysis was performed using the statistical soft-
ware STATA SE 12 (StataCorp LP, College Station, TX,




The PALLADIO study enrolled 1162 outpatients with a
clinical suspicion of DVT, with a median age of 66 years
and a prevalence of female sex (60%) [15]. D-dimer
results using the manufacturer’s cut-off were negative in
516 (44%) patients and positive in 646 (56%) patients.
Using the age-adjusted cut-off, D-dimer was negative in
632 (54%) patients and positive in 530 (46%) patients,
resulting in a 10.0% (95% CI, 8.4–11.8%) decrease of
positive results that might need further assessment.
Combining the age-adjusted D-dimer with the Wells
PTP, which was likely in 575 patients (49%) and unlikely
in 587 patients (51%), 35.3% patients (n = 410) were clas-
sified in group 1 (unlikely PTP and negative D-dimer),
34.3% (n = 399) in group 2 (either likely PTP or positive
D-dimer) and 30.4% (n = 353) in group 3 (both likely
PTP and positive D-dimer). Baseline characteristics of
each group are reported in Table 1.
In the original analysis of the PALLADIO study,
30.2% patients (n = 351) were classified in group 1,
34.5% (n = 401) in group 2 and 35.3% (n = 410) in group
3. The age-adjusted D-dimer resulted in 59 more patients
assigned to group 1, who would have had a DVT
excluded without the need for CUS; 2 less patients
assigned to group 2; and 57 less patients assigned to
group 3, who would have had a proximal veins CUS
instead of a whole-leg CUS. Therefore, the age-adjusted
D-dimer would have resulted in a 5.1% (95% CI, 4.0–
6.5%) decrease of patients requiring an imaging test
(from 69.8% of patients needing a CUS with the original
D-dimer cut-off to 64.7% using the age-adjusted cut-off)
and a 4.9% (95% CI, 3.8–6.3%) decreased need for
extended CUS (from 35.3% of patients needing an
extended CUS with the original D-dimer cut-off to 30.4%
using the age-adjusted cut-off).
Venous thromboembolic events
Using the original group assignment, the number of
DVTs detected at the initial visit were 12 (3.0%) in group
2 and 200 (48.8%) in group 3, of which 82 were isolated
distal DVTs. Using the age-adjusted cut-off, the number
of DVTs detected at the initial visit became 16 (4.0%) in
group 2 and 187 (53.0%) in group 3, of which 73 were
isolated distal DVTs. Therefore, nine isolated distal
DVTs, previously diagnosed in group 3 (extended CUS),
would not have been detected at the initial visit if these
Table 1 Baseline characteristics of the population using the age-adjusted D-dimer threshold
Group 1 (n = 410) Group 2 (n = 399) Group 3 (n = 353)
Demographic characteristics
Age (years), median (IQR) 62 (44–75) 69 (54–79) 68 (51–80)
Female, n (%) 255 (62.2%) 244 (61.2%) 198 (56.1%)
Caucasian ethnicity, n (%) 397 (96.8%) 391 (98.0%) 340 (96.3%)
Clinical characteristics
Time from onset of symptoms to
assessment (days), median (IQR)
4 (2–7) 4 (2–7) 4 (2–7)
Involved leg:
Left, n (%) 204 (49.8%) 204 (51.1%) 194 (55.0%)
Right, n (%) 206 (50.2%) 195 (48.9%) 159 (45.0%)
Symptoms:
Whole leg, n (%) 69 (16.8%) 72 (18.1%) 107 (30.3%)
Thigh only, n (%) 19 (4.6%) 8 (2.0%) 6 (1.7%)
Calf only, n (%) 322 (78.5%) 319 (80.0%) 240 (68.0%)
Risk factors for DVT
Age > 65 years, n (%) 183 (44.6%) 224 (56.1%) 194 (55.0%)
Cancer, n (%) 11 (2.7%) 19 (4.8%) 35 (9.9%)
Reduced mobility, n (%) 60 (14.6%) 82 (20.6%) 103 (29.2%)
Long distance travel, n (%) 1 (0.2%) 6 (1.5%) 10 (2.8%)
Surgical intervention, n (%) 11 (2.7%) 16 (4.0%) 31 (8.8%)
Trauma or fracture, n (%) 41 (10.0%) 47 (11.8%) 35 (9.9%)
Hormonal therapy*, n (%) 14 (5.5%) 7 (2.9%) 15 (7.6%)
Acute medical disease, n (%) 18 (4.4%) 19 (4.8%) 29 (8.2%)
Personal history of VTE, n (%) 16 (3.9%) 11 (2.8%) 28 (7.9%)
Family history of VTE, n (%) 6 (1.5%) 6 (1.5%) 9 (2.6%)
Thrombophilia, n (%) 9 (2.2%) 5 (1.3%) 9 (2.6%)
DVT, deep vein thrombosis; IQR, interquartile range; VTE, venous thromboembolism. *Proportion calculated in women only.
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patients were included in group 2 (limited CUS). None of
the new 59 patients in group 1 (who were D-dimer posi-
tive with the conventional cut-off and therefore under-
went limited CUS in the original study) had DVT
diagnosed at baseline.
The overall incidence of VTE at 3 months in the PAL-
LADIO study was 0.87% (95% CI, 0.44–1.70%). Using
the age-adjusted cut-off, the number of symptomatic VTE
events during the 3-month follow-up and their distribu-
tion into the three groups would have remained the same
as those obtained with the manufacturer’s cut-off. The
incidence rates of VTE events using the two different
thresholds are summarized in Table 2. The results of the
sensitivity analysis confirmed the results of the principal
analysis (data not shown). Sensitivity and NPV of the
age-adjusted D-dimer were 89.5% (95% CI, 84.7–93.3%)
and 96.3% (95% CI, 94.5–97.6%), respectively (Table 3).
Discussion
To the best of our knowledge, this is the first time that
the age-adjusted D-dimer cut-off has been applied,
although in a post-hoc analysis, to an algorithm evaluat-
ing the need for limited or extended CUS in patients with
suspected DVT. Our results show that the age-adjusted
threshold included in the PALLADIO algorithm can
reduce by approximately 5% the need for imaging tests,
without increasing the incidence of VTE at the 3-month
follow-up.
A D-dimer cut-off that gradually increases with age has
been recently proposed to contrast the physiological rise of
D-dimer levels with older age and to reduce the false-
positive rates when used to rule out VTE in this popula-
tion. A meta-analysis of 13 study cohorts involving more
than 12 000 patients compared the conventional fixed
threshold (500 lg L1 for all patients) with an age-adjusted
threshold (defined as age 9 10 lg L1 for patients aged
> 50 years) [10]. The authors showed that specificity
increased from 57.6% to 62.3% in patients 51–60 years
old, from 39.4% to 49.5% in patients 61–70 years old,
from 24.5% to 44.2% in patients 71–80 years old, and
from 14.7% to 35.2% in patients > 80 years old, whereas
sensitivity remained > 97% in all age categories [10].
Furthermore, a recently published individual patients’
meta-analysis of more than 7000 patients with suspected
PE showed that the combination of the Wells score and the
age-adjusted D-dimer can increase by 5% the proportion
of patients who can be managed without imaging [11].
Our study supports this finding because the age-
adjusted cut-off was associated not only with a 5.1%
reduction of CUS overall, but also a 4.9% reduction of
extended CUS. Nonetheless, in our study the sensitivity
Table 2 Findings of the PALLADIO algorithm using the manufacturer’s and the age-adjusted D-dimer thresholds
Group 1 (no CUS) Group 2 (limited CUS) Group 3 (extended CUS)
Manufacturer’s D-dimer threshold (original PALLADIO study)
Patients enrolled, n 351 401 410
DVT detected at initial visit, n (%) 0 12 (3.0%) 200 (48.8%)
Patients eligible for follow-up*, n 351 371 202
VTE events during follow-up, n 1 4 3
VTE incidence (95% CI) 0.28% (0.05–1.60) 1.08% (0.42–2.74) 1.49% (0.51–4.27)
Age-adjusted D-dimer threshold
Patients enrolled, n 410 399 353
DVT detected at initial visit, n (%) 0 16† (4.0%) 187 (53.0%)
Patients eligible for follow-up*, n 409 356 159
VTE events during follow-up, n 1 4 3
VTE incidence (95% CI) 0.24% (0.04–1.37) 1.12% (0.44–2.85) 1.89% (0.64–5.40)
CI, confidence interval; CUS, compression ultrasound; DVT, deep vein thrombosis; VTE, venous thromboembolism. *Excluding protocol vio-
lations, as detailed in the original publication of the PALLADIO study [15]. †However, nine distal DVTs, previously diagnosed in group 3,
would not have been detected at the initial visit if included in group 2.
Table 3 Diagnostic accuracy of age-adjusted D-dimer
Overall population (n = 1136*) PTP unlikely (n = 580) PTP likely (n = 556)
Sensitivity (95% CI) 89.5% (84.7–93.3%) 87.5% (47.3–99.7%) 89.6% (84.7–93.4%)
Specificity (95% CI) 65.1% (61.9–68.2%) 71.3% (67.4–75.0%) 54.7% (49.2–60.0%)
Negative predictive value (95% CI) 96.3% (94.5–97.6%) 99.8% (98.6–100.0%) 89.5% (84.6–93.3%)
Positive predictive value (95% CI) 38.1% (33.9–42.4%) 4.1% (1.7–8.3%) 54.9% (49.5–60.2%)
PTP, pretest probability; CI, confidence interval. *Excluding 26 protocol violations, as detailed in the original publication of the PALLADIO
study [15].
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of the age-adjusted D-dimer was approximately 90%,
which is lower than the sensitivity reported in previously
published meta-analyses [2,17]. However, these estimates
are based on diagnostic studies evaluating only major
VTEs as outcomes (proximal DVT and/or PE), whereas
the sensitivity of D-dimer has been reported to be
approximately 84% in patients with suspected isolated
distal DVT [18]. Furthermore, in our study the sensitivity
and NPV of the age-adjusted D-dimer threshold (89.5%
and 96.3%, respectively) were lower than the sensitiv-
ity and NPV of the manufacturer’s threshold in the origi-
nal PALLADIO study (95.5% and 98.0%, respectively,
PALLADIO study Investigators, unpublished data). [Cor-
rections updated on December 23, 2017, after first online
publication: the preceding sentence was incorrectly edited
and has been corrected to include the percentages and the
correct citation information.] The increase in false-nega-
tive results with the age-adjusted D-dimer was due to 13
DVTs, all detected at the initial visit in patients originally
classified in group 3: nine isolated distal DVTs (that
would not have been detected if these patients were
shifted to group 2 [limited CUS]) and four proximal
DVTs (that would have been detected even with the lim-
ited CUS). Even though the natural history of these nine
unidentified distal DVTs cannot be ascertained, the inci-
dence rate of VTE during follow-up in the three patient
groups was similar to the original PALLADIO study.
The number of studies evaluating age-adjusted D-dimer
cut-offs has increased exponentially over the past years.
However, there was only one management study that
evaluated the age-adjusted threshold in patients with sus-
pected PE. In the ADJUST-PE study, patients with a
low/intermediate or unlikely PTP (calculated using the
revised Geneva score or the two-level Wells score) and a
negative D-dimer result (according to the age-adjusted
cut-off) had PE ruled out without CTPA [12]. During the
3-month follow-up there was one episode of VTE, corre-
sponding to a D-dimer failure rate of 0.3% (95% CI,
0.1–1.7%) [12]. Furthermore, the majority of previous
studies evaluated D-dimer tests with a standard fixed cut-
off of 500 lg L1 in fibrinogen-equivalent units (FEU),
and defined the age-adjusted cut-off as age 9 10 lg L1
for patients aged > 50 years [10–12,19]. However, some
laboratories use D-dimer tests that are expressed in D-
dimer units (D-DU) and have lower cut-offs, because 1
FEU corresponds to approximately 2 D-DU [16].
Two recently published studies evaluated lower age-
adjusted thresholds. Jaconelli et al. evaluated 1649 patients
admitted to the emergency department with a suspected
DVT or PE, and who had D-dimer testing [20]. Because the
HemosIL D-dimer is measured in D-DU and the conven-
tional cut-off is < 230 ng mL1, the authors compared the
standard cut-off level (230 ng mL1 in all patients) with a
halved age-adjusted threshold (defined as patients
age 9 5 ng mL1 for patients 50 years or older and
250 ng mL1 for patients younger than 50 years). Among
the 1324 patients with VTE unlikely (defined using the
dichotomized Wells score), the age-adjusted cut-off would
have resulted in almost 10% more patients with negative
D-dimer, in whom VTE could have been ruled out without
imaging and without any false-negative results [20]. Nobes
et al. evaluated 1000 consecutive patients with suspected
PE, who had both D-dimer testing and CTPA [21]. They
evaluated the same age-adjusted cut-off (patients
age 9 5 ng mL1 for patients 50 years or older and
250 ng mL1 for patients younger than 50 years) and
found that the combination of unlikely PTP (using the
revised Geneva score) and age-adjusted D-dimer would
have reduced unnecessary radiation exposure without miss-
ing any PE [21]. Because three participating centers in the
PALLADIO study used D-dimer tests with reduced thresh-
olds, we similarly decided to halve the age-adjusted cut-off
in patients older than 50 years, but we kept the conven-
tional fixed threshold for patients up to 50 years, as sug-
gested by a previous laboratory study [16]. However, our
results confirmed the safety of the approach proposed by
Jaconelli and Nobes [20,21].
The use of an age-adjusted D-dimer threshold has been
recently questioned by two studies. Takach Lapner et al.
compared three different D-dimer interpretations in 1649
patients with a first suspected DVT or PE: the classical age-
adjusted strategy (increasing D-dimer cut-off with increas-
ing age), an inverse age-adjusted strategy (increasing D-
dimer cut-off with decreasing age) and a mean D-dimer
strategy (the same higher D-dimer cut-off for all patients)
[13]. They found that the negative predictive value of D-
dimer was above 99%with all three strategies, thus conclud-
ing that the classical age-adjusted threshold did not provide
a better diagnostic strategy as compared with the mean D-
dimer strategy [13]. Pernod et al. evaluated 1196 patients
< 80 years old with suspected PE and found a similar per-
formance of the conventional and age-adjusted D-dimer
thresholds, the latter providing only a 2% increase of
patients reclassified as PE ruled out without imaging [14,22].
However, patients with high clinical probability of PTPwere
excluded in the first study [13] and constituted less than 2%
of the second study [14,22], probably because of the limited
value of D-dimer in this subgroup of patients who are sup-
posed to undergo imaging tests regardless of D-dimer value.
The PALLADIO study, instead, included also patients with
likely PTP of DVT, because the aim was not only to reduce
the need for CUS but also to identify which patients should
be examined for distal DVTs.
Our study has some limitations that need to be
acknowledged. First, the age-adjusted D-dimer threshold
was a post-hoc analysis of a management study with pre-
defined endpoints and data collection. However, for the
first time in patients with DVT, the age-adjusted D-dimer
cut-off has been evaluated inside a diagnostic algorithm,
including also clinical PTP and limited or extended CUS.
Second, different D-dimer assays have been utilized by
the participating centers; therefore, different age-adjusted
© 2017 International Society on Thrombosis and Haemostasis
276 N. Riva et al
thresholds had to be applied. However, the fact that
PALLADIO was an international multicenter study sug-
gests that the age-adjusted D-dimer can be safely applied
to different laboratory tests, provided that the cut-off is
accurately set according to the D-dimer expressed as
FEU or D-DU. Third, the reclassification of patients in a
lower group would have resulted in more limited CUS
and non-detection of nine isolated distal DVTs in patients
changed from group 3 (extended CUS) to group 2 (lim-
ited CUS) with the age-adjusted D-dimer. Hence, being a
post hoc analysis, it is not possible to evaluate the natural
history of distal DVTs in these patients without the inter-
ference of anticoagulant treatment, because in the PAL-
LADIO study an extended CUS was performed and they
were treated accordingly.
In conclusion, using an age-adjusted D-dimer cut-off in
combination with clinical PTP in patients with suspected
DVT can possibly decrease the number of required imag-
ing tests.
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